BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1797743)

  • 1. Studies on the effectiveness of sairei-to on puromycin aminonucleoside nephrosis in rats.
    Joarder ZH; Ogawa T; Yorioka N; Yamakido M
    Hiroshima J Med Sci; 1991 Dec; 40(4):127-35. PubMed ID: 1797743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
    Higuchi A
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low protein diet in puromycin aminonucleoside-induced nephrotic rats.
    Shibasaki T; Gomi H; Ishimoto F; Sakai O
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):871-5. PubMed ID: 2250404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of FK506 on aminonucleoside-induced nephrotic rats].
    Kawaguchi S
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):141-51. PubMed ID: 1375300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ; Wilke WL; Fettman MJ
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
    Sampaio-Maia B; Moreira-Rodrigues M; Serrão P; Pestana M
    Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical medullectomy does not prevent sodium retention in nephrotic rats.
    Keeler R
    Miner Electrolyte Metab; 1989; 15(4):241-5. PubMed ID: 2761491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
    Garin EH; Shirey AJ
    Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
    Yatsu T; Aoki M; Tanaka A
    Eur J Pharmacol; 2005 Mar; 510(1-2):121-6. PubMed ID: 15740732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal formula Qilong-Lishui granule improves puromycin aminonucleoside-induced renal injury through regulation of bone morphogenetic proteins.
    Li P; Yan J; Sun Y; Burczynski FJ; Gong Y
    Nephrology (Carlton); 2007 Oct; 12(5):466-73. PubMed ID: 17803470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric study of myocardial changes during puromycin aminonucleoside induced nephropathy in rats.
    van der Vijgh WJ; Van Velzen D; Van der Poort JS; Schlüper HM; Mross K; Feijen J; Pinedo HM
    Anticancer Res; 1987; 7(6):1111-5. PubMed ID: 3442408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
    Grond J; Elema JD
    Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.